Femasys Inc (FEMY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $11.89M
Last updated: Nov 17, 2026 at 4:15 PM ET
Femasys Inc (FEMY) Stock Chart
Femasys (FEMY) has a latest price of $1.12 on Nov 17, 2026. Its price fell 93.8% over the past 12 months. The month-end price fell 99.0% over the 5 years through Oct 2026, a compound annual decline of 60.3%.
Price Chart
From Jun 2021 to Oct 2026, its highest month-end close was $162.20 in Jun 2021 and its lowest $1.37 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart FEMY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for FEMY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 58.7%, and over 6 months it fell 84.4%. The month-end price fell 95.4% over the 3 years through Oct 2026, a compound annual decline of 64.1%.
| Period | Change |
|---|---|
| 1 month | -31.3% |
| 3 months | -58.7% |
| 6 months | -84.4% |
| 12 months | -93.8% |
| 12 months, with dividends | -93.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -95.4% | -64.1% |
| 5 years | -99.0% | -60.3% |
Price by Year
Its best calendar year was 2024, when the price rose 12.8%, and its weakest was 2022, when it fell 76.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.37 | -88.1% |
| 2025 | $11.52 | -47.6% |
| 2024 | $22.00 | +12.8% |
| 2023 | $19.50 | +8.3% |
| 2022 | $18.00 | -76.9% |
Trading Range
The price is 40.8% below its 50-day average of $1.89 and 79.6% below its 200-day average of $5.49.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.12 | |
| 50-day average | $1.89 | -40.8% |
| 200-day average | $5.49 | -79.6% |
Price Risk
Over 3 years, its largest fall from a peak was 97.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.99 |
| Largest fall, 1 year | -94.5% |
| Largest fall, 3 years | -97.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About FEMY
What is FEMY's 1-year price change?
Femasys's price fell 93.8% over the past 12 months. With dividends included, the 12-month total return was -93.8%.
What is FEMY's 5-year price change?
Femasys's month-end price fell 99.0% over the 5 years through Oct 2026, a compound annual decline of 60.3%. These figures leave out dividends.
What is FEMY's beta?
Femasys's 1-year beta against the S&P 500 is 1.99, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 94.5%.
Is the FEMY chart free?
Yes. Advanced Charting for FEMY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
FEMY pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors